New research on Marburg virus survivors identifies a key immunogen in the virus's wing domain, offering a promising target ...

Modex’s antibodies contain multiple binding sites and can target several parts of SARS-CoV-2’s spike protein, the tool the ...

OCP Global Summit ? Axiado Corporation, a leading AI-driven, hardware-anchored platform security solutions company, and Giga Computing, a subsidiary of GIGABYTE and an industry leader in generative AI ...

Hugel Inc., a leading global medical aesthetics company, announced that the Administrative Law Judge (ALJ) for its U.S. International Trade Commission (ITC) investigation issued the final ...

In neuroscience, antibodies are essential for investigating neurodegenerative disorders, facilitating early diagnosis and ...

While a JAMA study found a decline in mpox antibody responses after vaccination, a University of Oxford expert cautioned that ...

Abstract to be presented at the 5th annual HIV Research for Prevention Conference Study results highlight potential for ...

Immunity against mpox may be waning for those vaccinated with the modified vaccinia Ankara-Bavarian Nordic (MVA-BN; Jynneos) vaccine.

Studies showed that one month after the booster of mRNA-1273.214, participants who had previously received a vaccine and a 50 micrograms booster dose had a significantly higher neutralizing antibody ...

Mpox – formerly known as monkeypox – is rapidly spreading in several African countries, prompting the World Health ...

The mRNA-1273 COVID-19 booster dose was safe and elicited robust immune responses among children aged 6 months to 5 years and 6 to 11 years.

Llama Nanobodies: A Breakthrough in Building HIV Immunity July 17, 2024 — Biology researchers have developed a new antibody therapy that can neutralize a wide variety of HIV-1 strains.